Literature DB >> 11672423

Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A.

S Himpel1, P Panzer, K Eirmbter, H Czajkowska, M Sayed, L C Packman, T Blundell, H Kentrup, J Grötzinger, H G Joost, W Becker.   

Abstract

Protein kinases of the DYRK ('dual-specificity tyrosine-regulated kinase') family are characterized by a conserved Tyr-Xaa-Tyr motif (Tyr-319-Tyr-321) in a position exactly corresponding to the activation motif of the mitogen-activated protein kinase (MAP kinase) family (Thr-Xaa-Tyr). In a molecular model of the catalytic domain of DYRK1A, the orientation of phosphorylated Tyr-321 is strikingly similar to that of Tyr-185 in the known structure of the activated MAP kinase, extracellular-signal-regulated kinase 2. Consistent with our model, substitution of Tyr-321 but not of Tyr-319 by phenylalanine markedly reduced the enzymic activity of recombinant DYRK1A expressed in either Escherichia coli or mammalian cells. Direct identification of phosphorylated residues by tandem MS confirmed that Tyr-321, but not Tyr-319, was phosphorylated. When expressed in COS-7 cells, DYRK1A was found to be fully phosphorylated on Tyr-321. A catalytically inactive mutant of DYRK1A contained no detectable phosphotyrosine, indicating that Tyr-321 is autophosphorylated by DYRK1A. MS identified Tyr-111 and Ser-97 as additional autophosphorylation sites in the non-catalytic N-terminal domain of bacterially expressed DYRK1A. Enzymic activity was not affected in the DYRK1A-Y111F mutant. The present experimental data and the molecular model indicate that the activity of DYRK1A is dependent on the autophosphorylation of a conserved tyrosine residue in the activation loop.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672423      PMCID: PMC1222170          DOI: 10.1042/0264-6021:3590497

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  A new expression cloning strategy for isolation of substrate-specific kinases by using phosphorylation site-specific antibody.

Authors:  R Matsuo; W Ochiai; K Nakashima; T Taga
Journal:  J Immunol Methods       Date:  2001-01-01       Impact factor: 2.303

2.  Fission yeast Pom1p kinase activity is cell cycle regulated and essential for cellular symmetry during growth and division.

Authors:  J Bähler; P Nurse
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

3.  Specificity determinants of substrate recognition by the protein kinase DYRK1A.

Authors:  S Himpel; W Tegge; R Frank; S Leder; H G Joost; W Becker
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation.

Authors:  S Bellon; M J Fitzgibbon; T Fox; H M Hsiao; K P Wilson
Journal:  Structure       Date:  1999-09-15       Impact factor: 5.006

Review 5.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.

Authors:  S K Hanks; A M Quinn; T Hunter
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

6.  The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.

Authors:  Y L Woods; G Rena; N Morrice; A Barthel; W Becker; S Guo; T G Unterman; P Cohen
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

7.  Essential functions of protein tyrosine phosphatases PTP2 and PTP3 and RIM11 tyrosine phosphorylation in Saccharomyces cerevisiae meiosis and sporulation.

Authors:  X L Zhan; Y Hong; T Zhu; A P Mitchell; R J Deschenes; K L Guan
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

8.  Saccharomyces cerevisiae Yak1p protein kinase autophosphorylates on tyrosine residues and phosphorylates myelin basic protein on a C-terminal serine residue.

Authors:  S Kassis; T Melhuish; R S Annan; S L Chen; J C Lee; G P Livi; C L Creasy
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

9.  Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells.

Authors:  K Lee; X Deng; E Friedman
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

Review 10.  Distantly related cousins of MAP kinase: biochemical properties and possible physiological functions.

Authors:  Y Miyata; E Nishida
Journal:  Biochem Biophys Res Commun       Date:  1999-12-20       Impact factor: 3.575

View more
  64 in total

1.  Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.

Authors:  Arthur R Salomon; Scott B Ficarro; Laurence M Brill; Achim Brinker; Qui T Phung; Christer Ericson; Karsten Sauer; Ansgar Brock; David M Horn; Peter G Schultz; Eric C Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-09       Impact factor: 11.205

Review 2.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

3.  Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).

Authors:  Tatyana Adayev; Jerzy Wegiel; Yu-Wen Hwang
Journal:  Arch Biochem Biophys       Date:  2010-12-24       Impact factor: 4.013

4.  Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis.

Authors:  Almira Punjabi; Paula Traktman
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding.

Authors:  Mónica Alvarez; Xavier Altafaj; Sergi Aranda; Susana de la Luna
Journal:  Mol Biol Cell       Date:  2007-01-17       Impact factor: 4.138

6.  The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.

Authors:  Jerzy Wegiel; Karol Dowjat; Wojciech Kaczmarski; Izabela Kuchna; Krzysztof Nowicki; Janusz Frackowiak; Bozena Mazur Kolecka; Jarek Wegiel; Wayne P Silverman; Barry Reisberg; Mony Deleon; Thomas Wisniewski; Cheng-Xin Gong; Fei Liu; Tatyana Adayev; Mo-Chou Chen-Hwang; Yu-Wen Hwang
Journal:  Acta Neuropathol       Date:  2008-08-12       Impact factor: 17.088

7.  ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.

Authors:  Naoe Taira; Hiroyuki Yamamoto; Tomoko Yamaguchi; Yoshio Miki; Kiyotsugu Yoshida
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

8.  Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map to control the decision to enter the cell cycle.

Authors:  Jia-Yun Chen; Jia-Ren Lin; Feng-Chiao Tsai; Tobias Meyer
Journal:  Mol Cell       Date:  2013-10-10       Impact factor: 17.970

9.  Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A).

Authors:  Wojciech Kaczmarski; Madhabi Barua; Bozena Mazur-Kolecka; Janusz Frackowiak; Wieslaw Dowjat; Pankaj Mehta; David Bolton; Yu-Wen Hwang; Ausma Rabe; Giorgio Albertini; Jerzy Wegiel
Journal:  J Neurosci Res       Date:  2013-11-22       Impact factor: 4.164

10.  Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome.

Authors:  Juan Arranz; Elisa Balducci; Krisztina Arató; Gentzane Sánchez-Elexpuru; Sònia Najas; Alberto Parras; Elena Rebollo; Isabel Pijuan; Ionas Erb; Gaetano Verde; Ignasi Sahun; Maria J Barallobre; José J Lucas; Marina P Sánchez; Susana de la Luna; Maria L Arbonés
Journal:  Neurobiol Dis       Date:  2019-03-01       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.